title: [Severe pneumonia in the intensive care unit].
abstract: Pneumonia has a high morbidity and mortality and is responsible for significant healthcare costs. In Germany, two evidence-based recommendations for the treatment of pneumonia are available: the S3 Guideline for Prevention, Diagnosis and Treatment of Adult Patients with Community-acquired Pneumonia and the S3 Guideline on Epidemiology, Diagnosis and Treatment of Nosocomial Pneumonia. On this basis, individualised patient management as shown in this article may be established.
authors.affiliation: Klinik für Pneumologie und Deutsches Zentrum für Lungenforschung, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover, Deutschland. welte.tobias@mh-hannover.de.
authors.forename: T
authors.initials: T
authors.lastname: Welte
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D017714:Community-Acquired Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D003428:Cross Infection / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D019983:Guideline Adherence; D006801:Humans; D007362:Intensive Care Units; D009102:Multiple Organ Failure / Q000401:mortality; D018410:Pneumonia, Bacterial / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D011024:Pneumonia, Viral / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D012121:Respiration, Artificial; D018570:Risk Assessment
chemical_list: D000900:Anti-Bacterial Agents
keywords: Antibiotics; Community acquired pneumonia; Nosocomial pneumonia; Organ failure; Risk assessment